换一批摘要Provided herein is an antifolate predictive response signature for use in determining the response of a subject suffering from cancer to antifolate therapy. Also provided are methods and compositions for determining proliferation in a sample obtained from a subject suffering from cancer through the use of a proliferation gene signature as well as methods for predicting response of a subject suffering from cancer based on an assessment of proliferation in a sample obtained from the subject.
更多相关知识
申请/专利号
EP22782125A
申请日期
2022-03-30
公开/公告号
公开/公告日
2024-02-07
主分类号
A61P35/0020180101LI20221024BHEP（抗肿瘤药）
分类号
A61P35/0020180101LI20221024BHEP C12Q1/688620130101LI20221024BHEP A61P35/0420180101FI20221024BHEP C12Q2600/15820130101LA20230215BHEP C12Q2600/10620130101LA20230215BHEP C12Q2600/11220130101LA20230215BHEP
发明/设计人
学术成果认领
专利代理机构
Cooley (UK) LLP
国别省市代码
美国;US
- 浏览0
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
